Renal effects of fenoldopam in critically ill pediatric patients: A retrospective review

Pediatric Critical Care Medicine

Volumn 9, Issue 4, 2008, Pages 403-406

  Moffett, Brady S ^a   Mott, Antonio R ^b   Nelson, David P ^b   Goldstein, Stuart L ^b   Jefferies, John Lynn ^b,c  

^a Department of Pharmacy ^*  (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Anuria; Fenoldopam; Oliguria; Pediatrics; Renal insufficiency

Indexed keywords

AMINOGLYCOSIDE; CAPTOPRIL; CHLOROTHIAZIDE; CLONIDINE; CREATININE; DOPAMINE; FENOLDOPAM; FUROSEMIDE; HYDRALAZINE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ACUTE DISEASE; ADULT; ANURIA; ARTICLE; CENTRAL VENOUS PRESSURE; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; FEMALE; HEART SURGERY; HEMODYNAMICS; HUMAN; INFORMATION PROCESSING; KIDNEY INJURY; KIDNEY PERFUSION; MALE; OLIGURIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; UREA NITROGEN BLOOD LEVEL; URINE VOLUME; ADOLESCENT; BLOOD; CRITICAL ILLNESS; DIURESIS; DRUG EFFECT; INFANT; KIDNEY DISEASE; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CREATININE; CRITICAL ILLNESS; DIURESIS; DOPAMINE AGONISTS; FEMALE; FENOLDOPAM; HEMODYNAMICS; HUMANS; INFANT; KIDNEY DISEASES; MALE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 59449094369     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181728c25     Document Type: Article

References (22)

1. Mathur VS, Swan SK, Lambrecht LJ, et al.: The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 1999; 27:1832-11827.
2. Tumlin JA, Finkel KW, Murray PT, et al.: Fenoldopam mesylate in early acute tubular necrosis: A randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 2005; 46:26-34.
3. Strauser LM, Pruitt RD, Tobias JD: Initial experience with fenoldopam in children. Am J Ther 1999; 6:283-288.
4. Tobias JD: Controlled hypotension in children: A critical review of available agents. Paediatr Drugs 2002; 4:439-453.
5. Costello JM, Thiagarajan RR, Dionne RE, et al.: Initial experience with fenoldopam after cardiac surgery in neonates with an insufficient response to conventional diuretics. Pediatr Crit Care Med 2006; 7:28-33.
6. Suominen PK, Dickerson HA, Moffett BS, et al.: Hemodynamic effects of rescue protocol hydrocortisone in neonates with low cardiac output syndrome after cardiac surgery. Pediatr Crit Care Med 2005; 6:655-659.
7. Moffett BS, Orellana R: Use of fenoldopam to increase urine output in a patient with renal insufficiency secondary to septic shock: A case report. Pediatr Crit Care Med 2006; 7:600-602.
8. Sorof JM, Stromberg D, Brewer ED, et al.: Early initiation of peritoneal dialysis after surgical repair of congenital heart disease. Pediatr Nephrol 1999; 13:641-645.
9. Francis GS, Wilson BC, Rector TS: Hemodynamic, renal, and neurohumoral effects of a selective oral DA-1 receptor agonist (fenoldopam) in patients with congestive heart failure. Am Heart J 1988; 116:473-479.
10. Gillespie RS, Seidel K, Symons JM: Effect of fluid overload and dose of replacement fluid on survival in hemofiltration. Pediatr Nephrol 2004; 19:1394-1399.
11. Goldstein SL, Currier H, Graf CD, et al.: Outcome in children receiving continuous venovenous hemofiltration. Pediatrics 2001; 107: 1309-1312.
12. Goldstein SL, Somers MJ, Baum MA, et al.: Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 2005; 67:653-658.
13. Bokesch PM, Kapural MB, Mossad EB, et al.: Do peritoneal catheters remove pro-inflammatory cytokines after cardiopulmonary bypass in neonates? Ann Thorac Surg 2000; 70:639-643.
14. Singh NC, Kissoon N, al Mofada S, et al.: Comparison of continuous vs. intermittent furosemide administration in postoperative pediatric cardiac patients. Crit Care Med 1992; 20:17-21.
15. Garwood S, Swamidoss CP, Davis EA, et al.: A case series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction. J Cardiothorac Vasc Anesth 2003; 17:17-21.
16. Halpenny M, Lakshmi S, O'Donnell A, et al.: Fenoldopam: Renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia 2001; 56:953-960.
17. Morelli A, Ricci Z, Bellomo R, et al.: Prophylactic fenoldopam for renal protection in sepsis: A randomized, double-blind, placebocontrolled pilot trial. Crit Care Med 2005; 33:2451-2456.
18. Caimmi PP, Pagani L, Micalizzi E, et al.: Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2003; 17:491-494.
19. Brienza N, Malcangi V, Dalfino L, et al.: A comparison between fenoldopam and lowdose dopamine in early renal dysfunction of critically ill patients. Crit Care Med 2006; 34:707-714.
20. Bellomo R, Chapman M, Finfer S, et al.: Lowdose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356:2139-2143.
21. Debaveye YA, Van den Berghe GH: Is there still a place for dopamine in the modern intensive care unit? Anesth Analg 2004; B98: 461-468.
22. Shilliday IR, Quinn KJ, Allison ME: Loop diuretics in the management of acute renal failure: A prospective, double-blind, placebocontrolled, randomized study. Nephrol Dial Transplant 1997; 12:2592-2596.